Tegal Corporation (NASDAQ:TGAL) today announced that it has become an industry partner of HealthTech Capital, one of Silicon Valley’s most prominent investing groups in emerging healthcare technology companies.

HealthTech Capital invests in a portfolio of early-stage healthcare technology companies. HTC focuses on capital efficient companies that leverage mobility and information technologies to improve healthcare delivery and decrease healthcare costs. HealthTech companies improve existing providers workflow or, empower consumers to manage their chronic conditions or improve their wellness.

Tegal expects to have an active partnership with HTC, said Thomas Mika, the company’s President and Chief Executive Officer. Tegal currently has one portfolio company in healthcare technology, NanoVibronix Inc., a private company that develops medical devices and products that implement its proprietary therapeutic ultrasound technology.

“HealthTech Capital is an excellent partner for Tegal as we intensify our investment focus on a $2-trillion market that HTC has identified for healthcare technologies,” Mr. Mika said. “Government mandates and efficiency requirements are powerful growth drivers in this market, which is tailor-made for Tegal and our decades of leadership in semiconductors, MEMS and related technologies. We expect our partnership with HealthTech Capital to produce extraordinary investment opportunities for Tegal.”

About HealthTech Capital

HealthTech Capital is a leading Silicon Valley-based angel investing group that is pioneering the emerging HealthTech market where innovation improves healthcare delivery, empowers patients, and lowers costs. Founded by Anne DeGheest, Kathy La Porte, and Don Ross, HealthTech Capital has built a membership of industry leaders – successful entrepreneurs, executives, physicians, and venture capitalists – who fund and mentor new companies. For more information, please visit www.HealthTechCapital.com.

About Tegal

Since its founding in 1972, Tegal Corporation has been dedicated to the development and application of emerging technologies. In over 35 years of process development and equipment design, Tegal’s legacy is evident in the most advanced consumer and industrial products that incorporate microprocessors, magnetic memories, radio frequency ID chips, acoustic wave devices, sensors, LEDs, and an array of other semiconductor and MEMS devices fabricated by some of the world’s leading companies, including Tegal’s one-time parent, Motorola. Drawing on its historic technology leadership in manufacturing process technology that incorporated electro-magnetics, plasma physics, radio frequency control, and materials science, Tegal is currently engaged in the sponsorship of other related emerging technology areas, including photovoltaic (PV)-based solar power and medical devices. Tegal’s objective is to employ its know-how and resources to pursue these opportunities for growth and profitability in order to enhance its value for over 6,000 public shareholders. Tegal is headquartered in Petaluma, California. Please visit us on the web at www.tegal.com.

Tegal (NASDAQ:TGAL)
Historical Stock Chart
From Oct 2024 to Nov 2024 Click Here for more Tegal Charts.
Tegal (NASDAQ:TGAL)
Historical Stock Chart
From Nov 2023 to Nov 2024 Click Here for more Tegal Charts.